ClinicalTrials.gg
CompletedNCT00872898Updated Jan 14, 2014Results posted

Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism

A Phase 2 interventional study of Memantine - Extended Release (ER) and Placebo in Autism, sponsored by Forest Laboratories. Completed at 17 sites in United States. Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2014-01-14.

Sponsored by Forest Laboratories (part of AbbVie) · Phase 2, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
124
Allocation
Randomized
Ages
6 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 603 studies in Autistic Disorder with a site in United States — 123 open to participants now, 152 under way, 3 of them phase 3. Autistic Disorder · United States.

Enrollment
94th of 504
124 · median 44
Started
2009
with 27 others
Phase 2
95 of 603
11 open now
Registered
103rd of 603
by date

Among the 603 studies in Autistic Disorder with a site in United States, this one is the 94th largest by enrollment of the 504 interventional ones that give a count, is one of 28 that started in 2009, is one of 95 in phase 2, and was the 103rd registered.

Autistic Disorder

1,033 studies on the registry are indexed under Autistic Disorder; 269 are open to participants now.

Browse Autistic Disorder studies →

Open to participants now

123 of the 603 studies in Autistic Disorder with a site in United States are open now. Recruiting first, the newest first:

118 more — sign in →

All 123 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 183 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 143 (78%) stop at 75 or younger; 148 take children under 18; 56 take healthy volunteers.

This study: 6 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 603 studies in Autistic Disorder with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to investigate the safety and efficacy of memantine extended release, as well as its extent of absorption in pediatric patients with autism.

Read the detailed description

This is a multicenter, two-part study in pediatric (ages 6 to 18 years) patients diagnosed with autism.

Patients participating in Part One will receive a single open-label dose of memantine. Blood samples for pharmacokinetic analysis will be collected.

Part Two is a randomized, double-blind, placebo-controlled 12-week efficacy and safety study evaluating change in all core domains (social interactions, communication, and restricted interests and repetitive behaviors) of autism.

In the Forest autism trials conducted in children ages 6-12, dosing with an extended release formulation of memantine was weight-based. These weight based dose limits were selected to ensure exposure in terms of area under the curve (AUC) was less than the predefined limit of 2100 ng∙h/mL that represented a 10-fold lower exposure than observed at the NOAEL (No observed adverse effect level) of 15 mg/kg/day in juvenile rats.

The weight-based dose limits in these studies were as follows:

  • Group A: ≥ 60 kg; max 15 mg/day
  • Group B: 40-59 kg; max 9 mg/day
  • Group C: 20-39 kg; max 6 mg/day
  • Group D: \< 20 kg; max 3 mg/day
03

Conditions studied

  • Autism

Browse trials for

Keywords

  • autism
  • memantine
  • pediatric
  • Forest Laboratories
  • Autism in pediatric patients
04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Males or females ages 6 to 12 years
  • Diagnosis of autistic disorder, according to using Autism Diagnostic Interview-Revised and Autism Diagnostic Observation Schedule (modules 2 \& 3).
  • A knowledgeable caregiver capable of providing reliable information about the patient's condition, able to attend all clinic visits with the patient
  • Patients over age 12, only if they completed Study MEM-PK-21

Exclusion criteria

Exclusion Criteria:

  • Medical history of active epilepsy/seizure disorder except simple febrile seizures
  • Participation in any other clinical investigation using an experimental drug within 30 days of the start of this study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
124 participants (actual)

Study arms

  • Experimental
    1

    Once daily oral administration of memantine for 12 weeks.

    Drug: Memantine - Extended Release (ER)

  • Placebo comparator
    2

    Once daily oral administration of placebo for 12 weeks.

    Drug: Placebo

Interventions

  • Memantine - 3mg and 6mg capsules, dose ranging 3 - 18 mg/day in 4 weight groups, administered orally.

    Also known as: Namenda ER

  • DrugPlacebo

    Placebo capsules, once daily, oral administration.

06

What researchers measure

Primary outcomes

  1. Extent of Absorption of Memantine (Part One)

    Area under the plasma concentration vs. time curve (AUC) for memantine, as measured in units of nanogram x hours per milliliter.

    Time frame: Baseline to 144 hours. Measurements were taken 0 (predose), 4, 8, 24, 30, 48, 96 and 144 hours post-dose

  2. Change in Total Raw Score of Social Responsiveness Scale

    The Social Responsiveness Scale (SRS) is a 65-item informant-rated assessment, ranging from 0 (no impairment) to 195 (severe social impairment). Each item is associated with 1 of 5 subscales (social awareness, social cognition, social communication, social motivation and autistic mannerisms). Each item is rated on a 4-point scale from 1 (not true) to 4 (almost always true). The scores are then transposed to a scale from 0 to 3 and scores are summed within each of the 5 subscales. A higher score indicates greater severity of social impairment.

    Time frame: From Baseline to Week 12

Secondary outcomes

  1. Core Autism Treatment Scale-Improvement: Total Score

    The Core Autism Treatment Scale-Improvement (CATS-I) is based on rating 14 items from 1 (very much improved) to 7 (very much worse) with a total score ranging from 14 (improved) to 98 (worsened). The Core Autism Treatment Scale-Improvement (CATS-I) is designed to utilize a comparison between pretreatment ratings of Core Autism Treatment Scale-Severity (CATS-S) and ratings of improvement after start of therapy (CATS-I). Both parts of the CATS contain 14 items testing for social interaction (items 1-9) and communication (items 10-14). Each of these items is rated from 1 (indicating most benign) to 7 (indicating most severe).

    Time frame: At Week 12

  2. Core Autism Treatment Scale-Improvement: Social Interaction

    The Core Autism Treatment Scale-Improvement (CATS-I) Social Interaction Subscale is based on rating 9 items from 1 (very much improved) to 7 (very much worse) with a total score ranging from 9 (improved) to 63 (worsened). The Core Autism Treatment Scale-Improvement (CATS-I) is designed to utilize a comparison between pretreatment ratings of Core Autism Treatment Scale-Severity (CATS-S) and ratings of improvement after start of therapy (CATS-I). Both parts of the CATS contain 14 items testing for social interaction (items 1-9) and communication (items 10-14). Each of these items is rated from 1 (indicating most benign) to 7 (indicating most severe).

    Time frame: At Week 12

  3. Core Autism Treatment Scale-Improvement: Communication

    The Core Autism Treatment Scale-Improvement (CATS-I) Communication Subscale is based on rating 5 items from 1 (very much improved) to 7 (very much worse) with a total score ranging from 5 (improved) to 35 (worsened). The Core Autism Treatment Scale-Improvement (CATS-I) is designed to utilize a comparison between pretreatment ratings of Core Autism Treatment Scale-Severity (CATS-S) and ratings of improvement after start of therapy (CATS-I). Both parts of the CATS contain 14 items testing for social interaction (items 1-9) and communication (items 10-14). Each of these items is rated from 1 (indicating most benign) to 7 (indicating most severe).

    Time frame: At Week 12

  4. Change in Children's Communication Checklist-2 (CCC-2) - Speech Subscale

    The Children's Communication Checklist-2 (CCC-2) Speech Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

    Time frame: From Baseline to Week 12

  5. Change in Children's Communication Checklist-2 (CCC-2) - Syntax Subscale

    The Children's Communication Checklist-2 (CCC-2) Syntax Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

    Time frame: From Baseline to Week 12

  6. Change in Children's Communication Checklist-2 (CCC-2) - Semantics Subscale

    The Children's Communication Checklist-2 (CCC-2) Semantics Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

    Time frame: From Baseline to Week 12

  7. Change in Children's Communication Checklist-2 (CCC-2) - Coherence Subscale

    The Children's Communication Checklist-2 (CCC-2) Coherence Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

    Time frame: From Baseline to Week 12

  8. Change in Children's Communication Checklist-2 (CCC-2) - Initiation Subscale

    The Children's Communication Checklist-2 (CCC-2) Initiation Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

    Time frame: From Baseline to Week 12

  9. Change in Children's Communication Checklist-2 (CCC-2) - Scripted Language Subscale

    The Children's Communication Checklist-2 (CCC-2) Scripted Language Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

    Time frame: From Baseline to Week 12

  10. Change in Children's Communication Checklist-2 (CCC-2) - Context Subscale

    The Children's Communication Checklist-2 (CCC-2) Context Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

    Time frame: From Baseline to Week 12

  11. Change in Children's Communication Checklist-2 (CCC-2) - Nonverbal Communication Subscale

    The Children's Communication Checklist-2 (CCC-2) Nonverbal Communication Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

    Time frame: From Baseline to Week 12

  12. Change in Children's Communication Checklist-2 (CCC-2) - Social Relations Subscale

    The Children's Communication Checklist-2 (CCC-2) Social Relations Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

    Time frame: From Baseline to Week 12

  13. Change in Children's Communication Checklist-2 (CCC-2) - Interests Subscale

    The Children's Communication Checklist-2 (CCC-2) Interests Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

    Time frame: From Baseline to Week 12

07

Results

Posted Jan 14, 2014

Participant flow

Patients for Part One of the study were recruited during a 15 month period from April of 2009, to June of 2010. Patients for Part Two of the study were recruited for a 37 month period from April of 2009 to April of 2012. All study sites were located in the United States.

Part One - Open Label, Pharmacokinetics
Participant flow — Part One - Open Label, Pharmacokinetics
MilestonePlaceboMemantine
Started04
Completed04
Not completed00
Part Two - Double Blind
Participant flow — Part Two - Double Blind
MilestonePlaceboMemantine
Started6160
Completed5054
Not completed116
Withdrew: Adverse event43
Withdrew: Lack of efficacy10
Withdrew: Protocol violation10
Withdrew: Withdrawal by subject31
Withdrew: Lost to follow-up02
Withdrew: Other reasons20

Outcome measures

PrimaryExtent of Absorption of Memantine (Part One)

Area under the plasma concentration vs. time curve (AUC) for memantine, as measured in units of nanogram x hours per milliliter.

Time frame:
Baseline to 144 hours. Measurements were taken 0 (predose), 4, 8, 24, 30, 48, 96 and 144 hours post-dose
Reported as:
Mean · ng•h/mL
Extent of Absorption of Memantine (Part One)
ng•h/mLMemantine
Extent of Absorption of Memantine (Part One)682.53 ± 217.77
SecondaryCore Autism Treatment Scale-Improvement: Total Score

The Core Autism Treatment Scale-Improvement (CATS-I) is based on rating 14 items from 1 (very much improved) to 7 (very much worse) with a total score ranging from 14 (improved) to 98 (worsened). The Core Autism Treatment Scale-Improvement (CATS-I) is designed to utilize a comparison between pretreatment ratings of Core Autism Treatment Scale-Severity (CATS-S) and ratings of improvement after start of therapy (CATS-I). Both parts of the CATS contain 14 items testing for social interaction (items 1-9) and communication (items 10-14). Each of these items is rated from 1 (indicating most benign) to 7 (indicating most severe).

Time frame:
At Week 12
Reported as:
Least squares mean · units on a scale
Core Autism Treatment Scale-Improvement: Total Score
units on a scalePlaceboMemantine
Core Autism Treatment Scale-Improvement: Total Score50.4 ± 1.048.3 ± 1.0
Statistical analysis
  • Placebo vs Memantine · mixed-model for repeated measures · p = 0.1197 · Least squares mean difference: -2.2 · 95% CI -4.9 to 0.6
PrimaryChange in Total Raw Score of Social Responsiveness Scale

The Social Responsiveness Scale (SRS) is a 65-item informant-rated assessment, ranging from 0 (no impairment) to 195 (severe social impairment). Each item is associated with 1 of 5 subscales (social awareness, social cognition, social communication, social motivation and autistic mannerisms). Each item is rated on a 4-point scale from 1 (not true) to 4 (almost always true). The scores are then transposed to a scale from 0 to 3 and scores are summed within each of the 5 subscales. A higher score indicates greater severity of social impairment.

Time frame:
From Baseline to Week 12
Reported as:
Least squares mean · units on a scale
Change in Total Raw Score of Social Responsiveness Scale
units on a scalePlaceboMemantine
Change in Total Raw Score of Social Responsiveness Scale-9.5 ± 2.6-9.6 ± 2.5
Statistical analysis
  • Placebo vs Memantine · mixed-model for repeated measures · p = 0.9781 · Least squares mean difference: -0.1 · 95% CI -7.2 to 7.0
SecondaryCore Autism Treatment Scale-Improvement: Social Interaction

The Core Autism Treatment Scale-Improvement (CATS-I) Social Interaction Subscale is based on rating 9 items from 1 (very much improved) to 7 (very much worse) with a total score ranging from 9 (improved) to 63 (worsened). The Core Autism Treatment Scale-Improvement (CATS-I) is designed to utilize a comparison between pretreatment ratings of Core Autism Treatment Scale-Severity (CATS-S) and ratings of improvement after start of therapy (CATS-I). Both parts of the CATS contain 14 items testing for social interaction (items 1-9) and communication (items 10-14). Each of these items is rated from 1 (indicating most benign) to 7 (indicating most severe).

Time frame:
At Week 12
Reported as:
Least squares mean · units on a scale
Core Autism Treatment Scale-Improvement: Social Interaction
units on a scalePlaceboMemantine
Core Autism Treatment Scale-Improvement: Social Interaction32.4 ± 0.731.1 ± 0.6
Statistical analysis
  • Placebo vs Memantine · mixed-model for repeated measures · p = 0.1459 · Least squares mean difference: -1.4 · 95% CI -3.2 to 0.5
SecondaryCore Autism Treatment Scale-Improvement: Communication

The Core Autism Treatment Scale-Improvement (CATS-I) Communication Subscale is based on rating 5 items from 1 (very much improved) to 7 (very much worse) with a total score ranging from 5 (improved) to 35 (worsened). The Core Autism Treatment Scale-Improvement (CATS-I) is designed to utilize a comparison between pretreatment ratings of Core Autism Treatment Scale-Severity (CATS-S) and ratings of improvement after start of therapy (CATS-I). Both parts of the CATS contain 14 items testing for social interaction (items 1-9) and communication (items 10-14). Each of these items is rated from 1 (indicating most benign) to 7 (indicating most severe).

Time frame:
At Week 12
Reported as:
Least squares mean · units on a scale
Core Autism Treatment Scale-Improvement: Communication
units on a scalePlaceboMemantine
Core Autism Treatment Scale-Improvement: Communication18.0 ± 0.417.2 ± 0.4
Statistical analysis
  • Placebo vs Memantine · mixed-model for repeated measures · p = 0.1344 · Least squares mean difference: -0.8 · 95% CI -1.9 to 0.3
SecondaryChange in Children's Communication Checklist-2 (CCC-2) - Speech Subscale

The Children's Communication Checklist-2 (CCC-2) Speech Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

Time frame:
From Baseline to Week 12
Reported as:
Least squares mean · units on a scale
Change in Children's Communication Checklist-2 (CCC-2) - Speech Subscale
units on a scalePlaceboMemantine
Change in Children's Communication Checklist-2 (CCC-2) - Speech Subscale-0.4 ± 0.5-0.7 ± 0.5
Statistical analysis
  • Placebo vs Memantine · mixed-model for repeated measures · p = 0.7000 · Least squares mean difference: -0.2 · 95% CI -1.5 to 1.0
SecondaryChange in Children's Communication Checklist-2 (CCC-2) - Syntax Subscale

The Children's Communication Checklist-2 (CCC-2) Syntax Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

Time frame:
From Baseline to Week 12
Reported as:
Least squares mean · units on a scale
Change in Children's Communication Checklist-2 (CCC-2) - Syntax Subscale
units on a scalePlaceboMemantine
Change in Children's Communication Checklist-2 (CCC-2) - Syntax Subscale-1.1 ± 0.4-1.2 ± 0.4
Statistical analysis
  • Placebo vs Memantine · mixed-model for repeated measures · p = 0.9069 · Least squares mean difference: -0.1 · 95% CI -1.3 to 1.1
SecondaryChange in Children's Communication Checklist-2 (CCC-2) - Semantics Subscale

The Children's Communication Checklist-2 (CCC-2) Semantics Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

Time frame:
From Baseline to Week 12
Reported as:
Least squares mean · units on a scale
Change in Children's Communication Checklist-2 (CCC-2) - Semantics Subscale
units on a scalePlaceboMemantine
Change in Children's Communication Checklist-2 (CCC-2) - Semantics Subscale-0.2 ± 0.3-0.5 ± 0.3
Statistical analysis
  • Placebo vs Memantine · mixed-model for repeated measures · p = 0.4679 · Least squares mean difference: -0.3 · 95% CI -1.2 to 0.6
SecondaryChange in Children's Communication Checklist-2 (CCC-2) - Coherence Subscale

The Children's Communication Checklist-2 (CCC-2) Coherence Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

Time frame:
From Baseline to Week 12
Reported as:
Least squares mean · units on a scale
Change in Children's Communication Checklist-2 (CCC-2) - Coherence Subscale
units on a scalePlaceboMemantine
Change in Children's Communication Checklist-2 (CCC-2) - Coherence Subscale-1.2 ± 0.5-1.2 ± 0.5
Statistical analysis
  • Placebo vs Memantine · mixed-model for repeated measures · p = 0.9598 · Least squares mean difference: -0.0 · 95% CI -1.3 to 1.3
SecondaryChange in Children's Communication Checklist-2 (CCC-2) - Initiation Subscale

The Children's Communication Checklist-2 (CCC-2) Initiation Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

Time frame:
From Baseline to Week 12
Reported as:
Least squares mean · units on a scale
Change in Children's Communication Checklist-2 (CCC-2) - Initiation Subscale
units on a scalePlaceboMemantine
Change in Children's Communication Checklist-2 (CCC-2) - Initiation Subscale-0.8 ± 0.5-0.9 ± 0.4
Statistical analysis
  • Placebo vs Memantine · mixed-model for repeated measures · p = 0.9898 · Least squares mean difference: -0.0 · 95% CI -1.3 to 1.3
SecondaryChange in Children's Communication Checklist-2 (CCC-2) - Scripted Language Subscale

The Children's Communication Checklist-2 (CCC-2) Scripted Language Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

Time frame:
From Baseline to Week 12
Reported as:
Least squares mean · units on a scale
Change in Children's Communication Checklist-2 (CCC-2) - Scripted Language Subscale
units on a scalePlaceboMemantine
Change in Children's Communication Checklist-2 (CCC-2) - Scripted Language Subscale-1.0 ± 0.4-0.5 ± 0.4
Statistical analysis
  • Placebo vs Memantine · mixed-model for repeated measures · p = 0.4228 · Least squares mean difference: 0.5 · 95% CI -0.7 to 1.6
SecondaryChange in Children's Communication Checklist-2 (CCC-2) - Context Subscale

The Children's Communication Checklist-2 (CCC-2) Context Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

Time frame:
From Baseline to Week 12
Reported as:
Least squares mean · units on a scale
Change in Children's Communication Checklist-2 (CCC-2) - Context Subscale
units on a scalePlaceboMemantine
Change in Children's Communication Checklist-2 (CCC-2) - Context Subscale-1.5 ± 0.4-0.2 ± 0.4
Statistical analysis
  • Placebo vs Memantine · mixed-model for repeated measures · p = 0.0201 · Least squares mean difference: 1.4 · 95% CI 0.2 to 2.5
SecondaryChange in Children's Communication Checklist-2 (CCC-2) - Nonverbal Communication Subscale

The Children's Communication Checklist-2 (CCC-2) Nonverbal Communication Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

Time frame:
From Baseline to Week 12
Reported as:
Least squares mean · units on a scale
Change in Children's Communication Checklist-2 (CCC-2) - Nonverbal Communication Subscale
units on a scalePlaceboMemantine
Change in Children's Communication Checklist-2 (CCC-2) - Nonverbal Communication Subscale-0.7 ± 0.4-0.9 ± 0.4
Statistical analysis
  • Placebo vs Memantine · mixed-model for repeated measures · p = 0.6889 · Least squares mean difference: -0.2 · 95% CI -1.3 to 0.9
SecondaryChange in Children's Communication Checklist-2 (CCC-2) - Social Relations Subscale

The Children's Communication Checklist-2 (CCC-2) Social Relations Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

Time frame:
From Baseline to Week 12
Reported as:
Least squares mean · units on a scale
Change in Children's Communication Checklist-2 (CCC-2) - Social Relations Subscale
units on a scalePlaceboMemantine
Change in Children's Communication Checklist-2 (CCC-2) - Social Relations Subscale-1.0 ± 0.4-0.8 ± 0.4
Statistical analysis
  • Placebo vs Memantine · mixed-model for repeated measures · p = 0.7481 · Least squares mean difference: 0.2 · 95% CI -0.9 to 1.2
SecondaryChange in Children's Communication Checklist-2 (CCC-2) - Interests Subscale

The Children's Communication Checklist-2 (CCC-2) Interests Subscale consists of 7 items rated from 0 (less than once a week or never) to 3 (several times \[more than twice\] a day or always), with a total raw score of 0 (mildest) to 21 (most severe). The Children's Communication Checklist-2 (CCC-2) is a validated, norm-referenced, informant-rated scale that evaluates difficulties children may have (across 10 different subscales, consisting of 7 items each) that affect communication (items 1-50), as well as strengths that children may demonstrate when communicating with others (items 51-70).

Time frame:
From Baseline to Week 12
Reported as:
Least squares mean · units on a scale
Change in Children's Communication Checklist-2 (CCC-2) - Interests Subscale
units on a scalePlaceboMemantine
Change in Children's Communication Checklist-2 (CCC-2) - Interests Subscale-0.5 ± 0.4-0.5 ± 0.4
Statistical analysis
  • Placebo vs Memantine · mixed-model for repeated measures · p = 0.9500 · Least squares mean difference: -0.0 · 95% CI -1.2 to 1.1

Adverse events

Collected over Adverse event data for Part One of this study was collected over a 14-month period from May 2009 to July of 2010. Adverse event data for Part Two of this study was collected over a 38-month period from July of 2009 to September of 2012.. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Placebo - Part Two, Double-Blind Treatment—0/61 (0%)31/61 (50.8%)
Memantine - Part Two, Double-Blind Treatment—1/60 (1.7%)37/60 (61.7%)
Memantine - Part One, Open Label Treatment—0/4 (0%)1/4 (25%)
Most frequent serious events
Most frequent serious events
EventPlacebo - Part Two, Double-Blind TreatmentMemantine - Part Two, Double-Blind TreatmentMemantine - Part One, Open Label Treatment
Affective DisorderPsychiatric disorders0/611/600/4
Most frequent other events
Showing 10 of 15
Most frequent other events
EventPlacebo - Part Two, Double-Blind TreatmentMemantine - Part Two, Double-Blind TreatmentMemantine - Part One, Open Label Treatment
HeadacheNervous system disorders3/613/601/4
Upper respiratory tract infectionInfections and infestations7/616/600/4
CoughRespiratory, thoracic and mediastinal disorders3/616/600/4
VomitingGastrointestinal disorders6/614/600/4
NasopharyngitisInfections and infestations6/612/600/4
IrritabilityGeneral disorders3/615/600/4
AggressionPsychiatric disorders3/615/600/4
Nasal congestionRespiratory, thoracic and mediastinal disorders5/611/600/4
InfluenzaInfections and infestations2/614/600/4
AgitationPsychiatric disorders1/614/600/4

Baseline characteristics

Part One of the study enrolled 4 patients to determine a safe dosing regimen for Part Two along with data collected for 14 patients enrolled in study MEM-PK-21. One patient from Part One of the study also enrolled in Part Two. The 121 patients enrolled in Part Two were randomized after two weeks of single-blind placebo treatment.

Age, Continuous
Age, Continuous(years)Part One - MemantinePart Two - PlaceboPart Two - MemantineTotal
6 years to 18 years9.0 ± 2.68.9 ± 2.29.0 ± 2.29.0 ± 0.1
Age, Customized
Age, Customized(participants)Part One - MemantinePart Two - PlaceboPart Two - MemantineTotal
6 years to 12 years36059122
13 years to 18 years0112
Sex: Female, Male
Sex: Female, Male(Participants)Part One - MemantinePart Two - PlaceboPart Two - MemantineTotal
Female212822
Male14952102
Region of Enrollment
Region of Enrollment(participants)Part One - MemantinePart Two - PlaceboPart Two - MemantineTotal
United States36160124
08

Study locations

17 sites
  • Forest Investigative Site
    Phoenix, Arizona 85006, United States
  • Forest Investigative Site
    Sacramento, California 95817, United States
  • Forest Investigative Site
    San Francisco, California 94143, United States
  • Forest Investigative Site
    Santa Ana, California 92705, United States
  • Forest Investigative Site
    Stanford, California 94305, United States
  • Forest Investigative Site
    Jacksonville Beach, Florida 32250, United States
  • Forest Investigative Site
    St Petersburg, Florida 33701, United States
  • Forest Investigative Site
    Hoffman Estates, Illinois 60169, United States
  • Forest Investigative site
    Naperville, Illinois 60563, United States
  • Forest Investigative Site
    Indianapolis, Indiana 46202, United States
  • Forest Investigative Site
    Cambridge, Massachusetts 02138, United States
  • Forest Investigative Site
    Toms River, New Jersey 08755, United States
  • Forest Investigative Site
    Voorhees, New Jersey 08043, United States
  • Forest Investigative Site
    Manhasset, New York 11030, United States
  • Forest Investigative Site
    Cleveland, Ohio 44106, United States
  • Forest Investigative Site
    Columbus, Ohio 43210, United States
  • Forest Investigative Site
    Oklahoma City, Oklahoma 73116, United States
09

References and documents

Publications

  • Brignell A, Marraffa C, Williams K, May T. Memantine for autism spectrum disorder. Cochrane Database Syst Rev. 2022 Aug 25;8(8):CD013845. doi: 10.1002/14651858.CD013845.pub2. PubMed 36006807 ↗
10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2009 and a primary completion of Aug 2012. It does not say whether these dates are actual or estimated.

Results were first posted in Jan 2014, 1 year 5 months after primary completion. A results delay was requested in Aug 2012.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 30, 2009
First posted
Mar 31, 2009
Start
Apr 2009
Primary completionActual
Aug 2012
Results delay requested
Aug 16, 2012
Results first posted
Jan 14, 2014
Last update
Jan 14, 2014
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 14, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00872898
Responsible party
Sponsor
First posted
Mar 31, 2009
Start date
Apr 2009
Primary completion
Aug 2012
Results posted
Jan 14, 2014
Last update
Jan 14, 2014

Study contacts

Ephraim Katz, PhD
study director · Forest Research Institute, a subsidiary of Forest Laboratories, Inc.

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Memantine

Start the discussion